GlassScriptPhysician profile
Hana Choe
NPI 1336301571
$85,938.10
in general payments reported to CMS, 2019-2025
24 companies · $34K in 2025
The $34K reported for 2025 was more than what 95% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,054 · 2020: $32.05 · 2021: $464 · 2022: $1,245 · 2023: $22K · 2024: $25K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $56K · Travel and Lodging: $17K · Food and Beverage: $8,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $56,085.00 |
| Travel and Lodging | $16,769.92 |
| Food and Beverage | $8,288.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $53,675.81 | 2021-2025 | Surpass Evolve, Flowgate, Trevo |
| Medical Device Business Services, INC. | $22,354.56 | 2024-2025 | Emboguard, Embotrap, Trufill |
| Penumbra, INC. | $4,200.33 | 2019-2025 | Penumbra System, Ruby Coil, Penumbra Coil 400 |
| Depuy Synthes Sales INC. | $2,492.33 | 2021-2025 | Trufill, N/A, Cerepak Uniform |
| Microvention, INC. | $1,611.20 | 2022-2025 | Web Aneurysm Embolization System, Stent, Hydrosoft Advanced |
| Medtronic, INC. | $402.97 | 2023-2025 | Pipeline, Rist, Solitaire X |
| Cardiofocus, INC. | $244.88 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $169.71 | 2023 | Artis Icono Biplane |
| Medtronic USA, INC. | $125.00 | 2019 | |
| Balt USA, LLC | $91.93 | 2025 | Carrier Delivery Catheter |
| Route 92 Medical, INC. | $88.92 | 2025 | |
| Alexion Pharmaceuticals, INC. | $80.20 | 2022 | |
| Sunovion Pharmaceuticals INC. | $78.79 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $47.44 | 2020-2021 | |
| Abbott Laboratories | $44.06 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $35.69 | 2025 | Kcentra |
| Lundbeck LLC | $35.42 | 2024-2025 | Rexulti |
| Axsome Therapeutics, INC. | $31.79 | 2025 | Symbravo |
| Abiomed | $26.32 | 2024 | Impella |
| Hoffmann-La Roche Limited | $25.00 | 2021 | |
| Genentech USA, INC. | $23.65 | 2023 | |
| Imperative Care, INC | $21.11 | 2024 | Zoom 88-T Large Distal Platform |
| Immedica Pharma US, INC. | $16.96 | 2024 | |
| Pfizer INC. | $14.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hana Choe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.